Hormonal, Reproductive Factors Linked to RA Risk Among Women
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Jan. 10, 2024 -- Certain hormonal and reproductive factors are associated with an increased risk for rheumatoid arthritis (RA) among women, according to a study published online Jan. 9 in RMD Open.
Ling-Qiong Jiang, from the Anhui Medical University School of Public Health in Hefei, China, and colleagues collected data on hormonal and reproductive factors in women from a prospective cohort of 223,526 U.K. Biobank participants to examine the association with RA risk.
The researchers identified 3,313 women with RA during a median follow-up of 12.39 years. Compared with menarche at 13 years, menarche at >14 years was associated with increased RA risk (hazard ratio [HR], 1.13). For women with menopause at younger than 45 years, the multiple adjusted HR for RA was 1.46. The risk for RA was increased with reproductive years <33 (HR, 1.39). Women with at least four versus two children had a higher risk for RA (HR, 1.18). The risk for RA was higher among those with a hysterectomy or oophorectomy versus those without (HRs, 1.40 and 1.21, respectively). Hormone replacement therapy use and duration were both associated with an increased risk for RA (HRs, 1.46 and 1.02, respectively).
"The findings of this study are significant and form a basis on which novel and target-specific intervention measures to curb the risk of RA in women may be developed," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-01-11 00:15
Read more
- FDA Approves Itovebi for Locally Advanced, Metastatic Breast Cancer
- Big Post-Election Surge Seen in Online Sales of Morning-After Pills
- AAO: Corneal Toxicity Reported With Mirvetuximab Soravtansine
- American College of Allergy, Asthma & Immunology, Oct. 24-28
- Oct. 7 Tragedy Spurs Israeli Researcher to Study Grief Over Sibling Loss
- Study Characterizes Pediatric Patients Self-Presenting With Major Trauma
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions